MedTrace Logo

Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining

NCT03516500 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-08-31

No results posted yet for this study

Summary

This is a protocol to determine the safety and feasibility of using Iron Sucrose Injection to identify the intersegmental plane,not only on the pleural surface but also the parenchyma of the lung.

Conditions

  • Lung Neoplasm
  • Segmentectomy;Intersegmental Plane

Interventions

DRUG

Iron Sucrose Injection

The investigators inject Iron Sucrose (100 mg dissolved in 50 mL saline) into the segmental bronchus.

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-09
Primary Completion
2021-01-21
Completion
2021-01-21

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03516500 on ClinicalTrials.gov